The Canadian COVID‑19 Funded Research Database

University of Alberta

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 51 through 60 of 67 results (Download Results)

Show results per page

Rapid Prototyping and Deployment of a Therapeutic Pan-Coronavirus Fusogenix DNA Vaccine Engineered to Eliminate ADE

Lewis, John D | University of Alberta | Operating Grant | $4,225,000

CIHR Alberta 2020

Detection and quantitation of SARS-CoV-2 in wastewater to conduct surveillance on burden of community infection, identify outbreaks and support public health decision-making on control measures for transmission of COVID-19

Pang, Xiaoli L | University of Alberta | Operating Grant | $487,859

CIHR Alberta 2020

Rapid RNA sequencing of coronavirus for public health surveillance and transmission

Croxen, Matthew A | University of Alberta | Operating Grant | $788,040

CIHR Alberta 2020

Mental health and substance use among children and adolescents amidst COVID-19- A Systematic Review

Meherali, Salima M | University of Alberta | Operating Grant | $46,886

CIHR Alberta 2020

Assessing and addressing the psychosocial impacts of COVID‑19 among pregnant women and health care providers in Anhui, China

Yamamoto, Shelby | University of Alberta | Operating Grant | $396,470

CIHR Alberta 2020

Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

Houghton, Michael | University of Alberta | Operating Grant | $750,000

CIHR Alberta 2020

Equity in Emergency Department Utilization in Alberta for Priority Populations during the COVID‑19 Pandemic: Exploring Impacts of Changes to Healthcare and Healthcare Utilization through Administrative Data Analysis and Nominal Group Techniques

McLane, Patrick | University of Alberta | Operating Grant | $93,837

CIHR Alberta 2020

Development and Evaluation of SARS-CoV-2 RNA Polymerase Inhibitors

Götte, Matthias | University of Alberta | Operating Grant | $675,000

CIHR Alberta 2020

Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV

Woodside, Michael T | University of Alberta | Operating Grant | $462,406

CIHR Alberta 2020

Broad-spectrum Antiviral Nasal Spray to Prevent and treat Infection by SARS-CoV2 and Seasonal Respiratory Viruses in High Risk Patients and Health Care Providers

Marchant, David J | University of Alberta | Operating Grant | $662,480

CIHR Alberta 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Rapid Prototyping and Deployment of a Therapeutic Pan-Coronavirus Fusogenix DNA Vaccine Engineered to Eliminate ADE

Detection and quantitation of SARS-CoV-2 in wastewater to conduct surveillance on burden of community infection, identify outbreaks and support public health decision-making on control measures for transmission of COVID-19

Rapid RNA sequencing of coronavirus for public health surveillance and transmission

Mental health and substance use among children and adolescents amidst COVID-19- A Systematic Review

Assessing and addressing the psychosocial impacts of COVID‑19 among pregnant women and health care providers in Anhui, China

Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses

Equity in Emergency Department Utilization in Alberta for Priority Populations during the COVID‑19 Pandemic: Exploring Impacts of Changes to Healthcare and Healthcare Utilization through Administrative Data Analysis and Nominal Group Techniques

Development and Evaluation of SARS-CoV-2 RNA Polymerase Inhibitors

Targeting programmed ribosomal frameshifting as a therapeutic strategy against 2019-nCoV

Broad-spectrum Antiviral Nasal Spray to Prevent and treat Infection by SARS-CoV2 and Seasonal Respiratory Viruses in High Risk Patients and Health Care Providers